FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly gastroenterology, and represents a pharmaceutical composition for prevention and treatment of infectious and noninfectious diarrheas, containing consisting of medicinal hydrolysed lignin and living cells of Saccharomyces boulardii yeast strain taken in amount 109-5x 1010 of living yeast cells per 1 gram of hydrolysed lignin.
EFFECT: invention provides the extended range of suppressed diarrhea agents, reduced variation and time of treatment of various other food toxicoinfection agents.
2 cl, 5 tbl, 1 dwg
Authors
Dates
2011-08-27—Published
2009-10-09—Filed